Compounds > galactose
Page last updated: 2024-08-17

galactose and rofecoxib

galactose has been researched along with rofecoxib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
d'Agostino, R; De Bartolo, L; Drioli, E; Favia, P; Giorno, L; Lopez, LC; Morelli, S; Rende, M; Salerno, S1
Alpert, E; Cohen, G; Gruzman, A; Lardi-Studler, B; Reich, R; Sasson, S1
Das, MK; Palei, NN1

Other Studies

3 other study(ies) available for galactose and rofecoxib

ArticleYear
Galactose derivative immobilized glow discharge processed polyethersulfone membranes maintain the liver cell metabolic activity.
    Journal of nanoscience and nanotechnology, 2006, Volume: 6, Issue:8

    Topics: Acrylates; Animals; Biocompatible Materials; Biotransformation; Galactose; Hepatocytes; Humans; Lactones; Liver; Membranes, Artificial; Nanotechnology; Polymers; Sugar Acids; Sulfones; Surface Properties; Swine

2006
Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner.
    Diabetologia, 2006, Volume: 49, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Activation; Hexoses; Insulin; Lactones; Male; Mice; Multienzyme Complexes; Muscle Fibers, Skeletal; Muscle, Skeletal; Niflumic Acid; Protein Serine-Threonine Kinases; Rats; Sulfonamides; Sulfones

2006
Sorbitan ester niosomes for topical delivery of rofecoxib.
    Indian journal of experimental biology, 2011, Volume: 49, Issue:6

    Topics: Administration, Topical; Animals; Cholesterol; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Delivery Systems; Gels; Hexoses; In Vitro Techniques; Lactones; Liposomes; Skin; Sulfones; Sus scrofa

2011